Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208162414> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W3208162414 endingPage "669" @default.
- W3208162414 startingPage "659" @default.
- W3208162414 abstract "Multiple myeloma (MM) is a malignancy of plasma cells; most MM patients will eventually relapse or become refractory to treatment. Treating MM patients remains a challenge since patients eventually progress through several lines of therapy (LOTs), requiring the use of multiple MM drug classes. We examined healthcare resource utilization (HCRU) and the costs incurred by MM patients following triple class exposure (TCE; defined as exposure to a proteosome inhibitor, an immunomodulatory agent, and an anti-CD-38 antibody).Adult MM patients were selected from the MarketScan® commercial and Medicare supplemental databases (January 2009-February 2021). From this cohort, patients who had TCE and ≥ 1 subsequent LOT that occurred after January 1, 2017 were included in the study population. The initiation date for the first post-TCE LOT was defined as the index date. All-cause and MM-related HCRU and the associated costs were examined post-index date.A total of 85 MM patients with TCE who initiated ≥ 1 subsequent LOT post-TCE and had ≥ 1 year of follow-up post-index date were included in the study population; mean age on index date was 58.8 years, and 60.0% were male. The time from first-observed MM diagnosis until index date averaged 47.5 months. During an average follow-up of 20.9 months post-index date, 64.7% of patients (N = 55) initiated a second LOT and 35.2% (N = 30) received at least 3 LOTs. During follow-up, mean total all-cause healthcare cost per patient was $722,992 (equivalent to $34,578 per patient per month [PPPM]). Approximately 90.7% ($655,524 per patient) of the total all-cause healthcare costs were MM related, 66.0% of which were MM drug/infusion costs.In this real-world US study, MM patients with TCE incurred high healthcare costs, with the majority being MM related and primarily attributed to MM drug and infusion costs." @default.
- W3208162414 created "2021-11-08" @default.
- W3208162414 creator A5008057051 @default.
- W3208162414 creator A5028046297 @default.
- W3208162414 creator A5053904944 @default.
- W3208162414 creator A5062185552 @default.
- W3208162414 creator A5075257656 @default.
- W3208162414 creator A5083313545 @default.
- W3208162414 creator A5087850384 @default.
- W3208162414 date "2021-10-25" @default.
- W3208162414 modified "2023-10-13" @default.
- W3208162414 title "Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US" @default.
- W3208162414 cites W2460376887 @default.
- W3208162414 cites W2588087999 @default.
- W3208162414 cites W2909071270 @default.
- W3208162414 cites W3004624445 @default.
- W3208162414 cites W3081477337 @default.
- W3208162414 cites W3092155144 @default.
- W3208162414 cites W3110289189 @default.
- W3208162414 doi "https://doi.org/10.1007/s40487-021-00175-z" @default.
- W3208162414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8593112" @default.
- W3208162414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34694578" @default.
- W3208162414 hasPublicationYear "2021" @default.
- W3208162414 type Work @default.
- W3208162414 sameAs 3208162414 @default.
- W3208162414 citedByCount "6" @default.
- W3208162414 countsByYear W32081624142021 @default.
- W3208162414 countsByYear W32081624142022 @default.
- W3208162414 countsByYear W32081624142023 @default.
- W3208162414 crossrefType "journal-article" @default.
- W3208162414 hasAuthorship W3208162414A5008057051 @default.
- W3208162414 hasAuthorship W3208162414A5028046297 @default.
- W3208162414 hasAuthorship W3208162414A5053904944 @default.
- W3208162414 hasAuthorship W3208162414A5062185552 @default.
- W3208162414 hasAuthorship W3208162414A5075257656 @default.
- W3208162414 hasAuthorship W3208162414A5083313545 @default.
- W3208162414 hasAuthorship W3208162414A5087850384 @default.
- W3208162414 hasBestOaLocation W32081624141 @default.
- W3208162414 hasConcept C121332964 @default.
- W3208162414 hasConcept C126322002 @default.
- W3208162414 hasConcept C142424586 @default.
- W3208162414 hasConcept C160735492 @default.
- W3208162414 hasConcept C162324750 @default.
- W3208162414 hasConcept C194828623 @default.
- W3208162414 hasConcept C2776364478 @default.
- W3208162414 hasConcept C2779399171 @default.
- W3208162414 hasConcept C2908647359 @default.
- W3208162414 hasConcept C50522688 @default.
- W3208162414 hasConcept C71924100 @default.
- W3208162414 hasConcept C72563966 @default.
- W3208162414 hasConcept C87355193 @default.
- W3208162414 hasConcept C99454951 @default.
- W3208162414 hasConceptScore W3208162414C121332964 @default.
- W3208162414 hasConceptScore W3208162414C126322002 @default.
- W3208162414 hasConceptScore W3208162414C142424586 @default.
- W3208162414 hasConceptScore W3208162414C160735492 @default.
- W3208162414 hasConceptScore W3208162414C162324750 @default.
- W3208162414 hasConceptScore W3208162414C194828623 @default.
- W3208162414 hasConceptScore W3208162414C2776364478 @default.
- W3208162414 hasConceptScore W3208162414C2779399171 @default.
- W3208162414 hasConceptScore W3208162414C2908647359 @default.
- W3208162414 hasConceptScore W3208162414C50522688 @default.
- W3208162414 hasConceptScore W3208162414C71924100 @default.
- W3208162414 hasConceptScore W3208162414C72563966 @default.
- W3208162414 hasConceptScore W3208162414C87355193 @default.
- W3208162414 hasConceptScore W3208162414C99454951 @default.
- W3208162414 hasFunder F4320337449 @default.
- W3208162414 hasIssue "2" @default.
- W3208162414 hasLocation W32081624141 @default.
- W3208162414 hasLocation W32081624142 @default.
- W3208162414 hasLocation W32081624143 @default.
- W3208162414 hasLocation W32081624144 @default.
- W3208162414 hasOpenAccess W3208162414 @default.
- W3208162414 hasPrimaryLocation W32081624141 @default.
- W3208162414 hasRelatedWork W125438382 @default.
- W3208162414 hasRelatedWork W1973936169 @default.
- W3208162414 hasRelatedWork W2354239783 @default.
- W3208162414 hasRelatedWork W2366743523 @default.
- W3208162414 hasRelatedWork W2377100155 @default.
- W3208162414 hasRelatedWork W2793887421 @default.
- W3208162414 hasRelatedWork W3153228984 @default.
- W3208162414 hasRelatedWork W4247453431 @default.
- W3208162414 hasRelatedWork W4253070239 @default.
- W3208162414 hasRelatedWork W4312779314 @default.
- W3208162414 hasVolume "9" @default.
- W3208162414 isParatext "false" @default.
- W3208162414 isRetracted "false" @default.
- W3208162414 magId "3208162414" @default.
- W3208162414 workType "article" @default.